ER
Esther Rajavelu
DELAYED 1 MONTH
Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Spero Therapeutics, Inc.
Filings
1
Companies
1
Latest
May 4, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
55
Spero Therapeutics, Inc.
Esther Rajavelu
Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Sale
$63.4K
25,240 sh
May 7 1:53 AM
May 4, 2026